Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Ameloblastic carcinoma: a rare entity.

Veena Maheshwari¹, Manoranjan Varshney, Kiran Alam

¹Department of Pathology, JN Medical College, Aligarh, India.

BMJ Case Reports

|June 16, 2012

Summary

Ameloblastic carcinoma, a rare aggressive odontogenic tumor, typically presents as a rapidly growing mandibular swelling. Surgical removal and radiotherapy are the standard treatments for this malignant tumor.

Related Concept Videos

Skin Cancer

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

Metastasis

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Rare CNS manifestation of high-risk CLL with excellent response to triplet targeted therapy.

Leukemia research reports·2026

Same author

The Oncology Research Information Exchange Network (ORIEN) - Building a Real-World Collaborative, Patient-driven Infrastructure for Discovery Research and Precision Oncology.

Research square·2026

Same author

Outcomes of hematopoietic stem cell transplantation in adult sickle cell disease patients: A Single-Center experience from India.

Annals of hematology·2026

Same author

Pearson Syndrome: Diagnostic Challenges and a Case of Successful Haploidentical Hematopoietic Stem Cell Transplantation.

Pediatric blood & cancer·2026

Same author

Primary intestinal lymphangiectasia presenting with intussusception in a child.

La Pediatria medica e chirurgica : Medical and surgical pediatrics·2026

Same author

Hydatid Cyst Masquerading as Chronic Sialadenitis-an Extremely Rare Locale of Zoonotic Disease Demystified by Cytology.

Iranian journal of otorhinolaryngology·2026

Area of Science:

Oral pathology
Oncology
Odontogenic tumors

Background:

Ameloblastic carcinoma is a rare, aggressive malignant epithelial odontogenic tumor.
It affects a wide age range with no sex predilection.
Clinical presentation often includes a rapidly enlarging swelling, commonly in the mandible.

Observation:

This report details a case of ameloblastic carcinoma in a 35-year-old male patient.
The tumor was located in the posterior mandible.
The patient presented with a rapidly enlarging swelling.

Findings:

Ameloblastic carcinoma is characterized by its aggressive nature and malignant epithelial origin.
The tumor's typical location is the posterior mandible.
Rapidly enlarging swelling is a common presenting symptom.

Related Experiment Videos

Implications:

Early diagnosis and prompt treatment are crucial for managing ameloblastic carcinoma.
Surgical excision combined with radiotherapy remains the primary treatment modality.
Further research into the pathogenesis and optimal management strategies for this rare tumor is warranted.